Pharmacokinetic (PK) studies for RXFP1-agonists

Name: Pharmacokinetic (PK) studies for RXFP1-agonists
Creator: NATIONAL INSTITUTES OF HEALTH
Published: 2026-08-07T00:00:00+00:00
Keywords: CONTRACT

NATIONAL INSTITUTES OF HEALTHHEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.NATIONAL INSTITUTES OF HEALTH OLAO

AI Overview

Commercial testing services for pharmacokinetic studies of RXFP1-agonist compounds. NIH seeks laboratory testing and analysis services for pharmaceutical research.

This summary is AI-generated from the official solicitation.

Key Details

Agency

NATIONAL INSTITUTES OF HEALTH

Funding Amount

—

Release Date

August 7, 2026

Due Date

August 24, 2026 (Closed)

Official Description

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes only solicitation; proposals are being requested, and a separate written solicitation will not be issued.(ii) The solicitation number is 75N98026Q00976. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Governme...

View on official source

Change History

Opportunity AddedAug 7, 2026 at 5:03 PM

Pharmacokinetic (PK) studies for RXFP1-agonists

New SAM.gov opportunity: Pharmacokinetic (PK) studies for RXFP1-agonists

Similar Opportunities

Active

FY26 Psychological Assessment Tools

Due September 4, 2026

Get Alerts for Opportunities Like This

RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.

Start Free Trial